Abstract
Marco Moscarelli, Thanos Athanasiou, Roberto Casula, Vincenzo Pernice, Massimo Salardino, Gregorio Zaccone, Adriana Złahoda-Huzior, Sabrina Milo, Giuseppe Speziale, Khalil Fattouch
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial
10.1093/eurheartj/ehae043 · 2024
Transcatheter vs surgical aortic valve replacement in lower-risk patients: an updated meta-analysis of randomized controlled trials
10.1016/j.jacc.2024.12.031 · 2025
ESC/EACTS Scientific DocumentGroup. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025;46:4635-4736. https://doi.org/10.1093/eurheartj/ehaf194
Kept as external metadata until matched
Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial
10.1093/eurheartj/ehae331 · 2024
Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes
10.1161/circulationaha.121.058339 · 2022
Post-implant transcatheter aortic prosthesis deformation: tricuspid versus bicuspid valve
10.1093/ejcts/ezae451 · 2024
Predictors of outcomes of reintervention after transcatheter aortic valve replacement: FRANCE 2 and FRANCE TAVI registries
10.1016/j.jacc.2024.11.048 · 2025
Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure
10.1007/s10741-018-9726-8 · 2018
Systematic CT methodology for the evaluation of subclinical leaflet thrombosis
10.1016/j.jcmg.2017.02.005 · 2017
Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trial
10.1038/s41467-025-61916-6 · 2025
Bioprosthetic aortic valve leaflet thickening in the evolut low risk sub-study
10.1016/j.jacc.2020.03.022 · 2020
Valvular and perivalvular thrombosis following self-expandable aortic valve replacement: analysis of 100 multi-detector computed tomography scans
10.1093/ehjopen/oeae085 · 2024
Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy
10.1016/j.jacc.2020.04.043 · 2020
Visualizing the effects of predictor variables in black box supervised learning models
10.1111/rssb.12377 · 2020
Unresolved referenced work
Kept as external metadata until matched
Greedy function approximation: a gradient boosting machine
10.1214/aos/1013203451 · 2001
Assisted artificial intelligence in medical writing: a primer for humans
10.1093/ejcts/ezaf167 · 2025
10.1145/2939672.2939785
10.1145/2939672.2939785
Predicting subclinical leaflet thrombosis in self-expandable prosthesis: a multimodal machine learning analysis
10.1016/j.xjse.2025.100064 · 2025
Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration
10.1097/ede.0b013e3181577511 · 2007
Thrombocytopaenia after implantation of the Perceval S aortic bioprosthesis
10.1016/j.jtcvs.2019.07.046 · 2020
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR)
10.1016/j.ijcard.2016.08.260 · 2016
Three-dimensional analysis of subclinical leaflet thrombosis following transcatheter aortic valve replacement
10.1093/ehjci/jeae051 · 2024
Bicuspid aortic valve disease: classifications, treatments, and emerging transcatheter paradigms
10.1016/j.shj.2023.100227 · 2024
Acquired thrombocytopaenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes
10.1093/eurheartj/ehu082 · 2014
Subclinical leaflet thrombosis and subclinical aortic valve complex thrombosis in TAVR
10.1016/j.jacadv.2025.102085 · 2025
No additional external references are available.